Nidan Laboratories Statements
NI
Data from Nidan Laboratories`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
30 Sep, 2023
Next reporting period:
28 Mar, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Nidan Laboratories Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
118.24
16.2 %
100
6.355
5.4
111.89
14.4 %
94.6
—
0
22.795
19.3
20.317
34.8 %
17.2
91.572
10.7 %
77.4
-9.769
-8.3
-55.785
-47.2
26.018
45.4 %
22
6.793
5.7
19.225
57.4 %
16.3
1.38
13.931
101.77
-27.8 %
100
3.965
3.9
97.808
-27 %
96.1
—
0
28.481
28
15.067
-53.8 %
14.8
82.741
-18.4 %
81.3
-11.907
-11.7
-52.936
-52.01
17.898
-40.8 %
17.6
5.684
5.6
12.214
-47.3 %
12
0.878
13.919
140.89
-52.5 %
100
6.925
4.9
133.96
-49.6 %
95.1
—
0
21.507
15.3
32.61
-44.8 %
23.1
101.35
-51 %
71.9
-10.324
-7.3
-60.809
-43.2
30.218
-33.2 %
21.4
7.036
5
23.182
-12.9 %
16.5
1.67
13.881
296.6
241.4 %
100
30.892
10.4
265.71
268.6 %
89.6
—
0
36.752
12.4
59.037
248.6 %
19.9
206.67
274.7 %
69.7
-26.648
-9
-134.82
-45.5
45.205
389.1 %
15.2
18.575
6.3
26.63
271.8 %
9
2.322
11.467
86.887
10.9 %
100
14.794
17
72.093
-3.2 %
83
—
0
8.002
9.2
16.937
4.4 %
19.5
55.156
-5.3 %
63.5
-8.118
-9.3
-37.796
-43.5
9.242
-34.1 %
10.6
2.079
2.4
7.163
-34.1 %
8.2
0.515
13.9
78.334
—
100
3.89
5
74.444
—
95
—
0
7.682
9.8
16.218
—
20.7
58.226
—
74.3
-9.069
-11.6
-35.126
-44.8
14.031
—
17.9
3.157
4
10.874
—
13.9
0.782
13.9